Over the last five years, an often forgotten piece of U.S. federal legislation – the…
Browsing: acute myleloid leukemia
Medication errors leading to death most commonly occur as a result of a patient not getting a medicine, in hospitals…
The FDA is warning that it has received a small number of serious reports of stroke and tears in the…
The leukemia drug Mylotarg (gemtuzumab ozogamicin), which was voluntarily withdrawn from the market in 2010 over safety concerns and questions…
About half of US doctors have received payments of some type from pharmaceutical and/or medical device companies amounting to $2.4…
About MedShadow
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
FIND ARTICLES
Conditions
Symptoms & Concerns
Medications
SUPPORT
Contribute
Donate
Contact
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward
